Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Schreiber, Hans

One or more keywords matched the following items that are connected to Schreiber, Hans

Item Type	Name
Concept	Antigens, Neoplasm
Concept	Antigens, Tumor-Associated, Carbohydrate
Academic Article	A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
Academic Article	DNA sequence analysis of T-cell receptor genes reveals an oligoclonal T-cell response to a tumor with multiple target antigens.
Academic Article	Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
Academic Article	Unique tumor antigens redefined as mutant tumor-specific antigens.
Academic Article	Tumor cells induce cytolytic T cells to a single immunodominant mutant peptide.
Academic Article	Point mutation in essential genes with loss or mutation of the second allele: relevance to the retention of tumor-specific antigens.
Academic Article	Tumor antigens.
Academic Article	MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
Academic Article	Complementary role of CD4+ T cells and secondary lymphoid tissues for cross-presentation of tumor antigen to CD8+ T cells.
Academic Article	Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors.
Academic Article	Specificity in cancer immunotherapy.
Academic Article	Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
Academic Article	A mutant chaperone converts a wild-type protein into a tumor-specific antigen.
Academic Article	Cancer. Quo vadis, specificity?
Academic Article	Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.
Academic Article	Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells.
Academic Article	Antigenic cancer cells that escape immune destruction are stimulated by host cells.
Academic Article	Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.
Academic Article	A unique tumor antigen produced by a single amino acid substitution.
Academic Article	Cancer. Awakening immunity.
Academic Article	Unique tumor-specific antigens.
Academic Article	Identification of a gene encoding a tumor-specific antigen that causes tumor rejection.
Academic Article	Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
Academic Article	[CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
Academic Article	Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
Academic Article	CD4-positive and B lymphocytes in transplantation immunity. I. Promotion of tumor allograft rejection through elimination of CD4-positive lymphocytes.
Academic Article	Equilibrium between host and cancer caused by effector T cells killing tumor stroma.
Academic Article	Tumor-specific immune responses.
Academic Article	Tumor-specific antigens and tumor-specific mutant proteins in mouse and man.
Academic Article	Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells.
Academic Article	Bystander elimination of antigen loss variants in established tumors.
Academic Article	Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
Academic Article	IL-15 in tumor microenvironment causes rejection of large established tumors by T cells in a noncognate T cell receptor-dependent manner.
Academic Article	MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR.
Academic Article	Antigen-specific bacterial vaccine combined with anti-PD-L1 rescues dysfunctional endogenous T cells to reject long-established cancer.
Academic Article	Targeting cancer-specific mutations by T cell receptor gene therapy.
Academic Article	Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.
Academic Article	Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Academic Article	Tumor-associated fibroblasts predominantly come from local and not circulating precursors.
Academic Article	Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1-Resistant Tumors Leading to Tumor Eradication.
Academic Article	Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cell.
Academic Article	Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.
Academic Article	Criteria to make animal studies more relevant to treating human cancer.
Concept	Cancer-Associated Fibroblasts
Grant	Manipulation of Tumor Specific Immunity
Grant	IMMUNITY AND CANCER
Grant	MANIPULATION OF TUMOR-SPECIFIC IMMUNITY

Search Criteria

Antigens Tumor
Associated
Carbohydrate